Clinical Trial

Use of Simucase for Clinical Learning in Malaysia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated December 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this feasibility study is to the investigate the use of Simucase in the context of health science learning in Malaysia. This study can be a catalyst for technology-based clinical learning than just conventional methods to enrich the learning experience. This can influence the policy in promoting the effective use of existing commercial technologies in clinical learning for health science programs in Malaysia and can transform national higher education scenario in the future. An experimental study with 24 participants from the rehabilitation disciplines of audiology, occupational therapy, physiotherapy, and speech therapy method using a pilot study techniques of clinical control studies. Participants will be assigned to either the experimental group who will receive the clinical learning method using SimucaseTM or (ii) the control group - which will accept conventional clinical learning methods such as problem-based learning case-study case studies. The topic of learning is the same for both groups. The study hypothesis includes: * There is a significant difference on clinical skills between SimucaseTM and conventional approach of learning among health science students. * There is a significant difference on students' satisfaction learning between SimucaseTM and conventional approach of learning among health science students.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-14.
Trial Details
NCT Number NCT06777550
Lead Sponsor National University of Malaysia
Collaborators: Universiti Putra Malaysia
Conditions Clinical Learning
Enrollment 24 participants
Start Date 2025-01-19
Primary Completion 2025-12-25 (estimated)
Study Completion 2025-12-25 (estimated)
Updated on ClinicalTrials.gov 2025-01-17